Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory lipids – Nature Biotechnology
Tenchov, R., Bird, R., Curtze, A. E. & Zhou, Q. Lipid nanoparticles—from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano 15, 16982–17015 (2021).
Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078–1094 (2021).
Google Scholar
Pardi, N. et al. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. J. Control. Release 217, 345–351 (2015).
Google Scholar
Herweijer, H. et al. Time course of gene expression after plasmid DNA gene transfer to the liver. J. Gene Med. 3, 280–291 (2001).
Google Scholar
Das, A. T., Tenenbaum, L. & Berkhout, B. Tet-On systems for doxycycline-inducible gene expression. Curr. Gene Ther. 16, 156–167 (2016).
Google Scholar
Arjomandnejad, M., Dasgupta, I., Flotte, T. R. & Keeler, A. M. Immunogenicity of recombinant adeno-associated virus (AAV) vectors for gene transfer. BioDrugs 37, 311–329 (2023).
Google Scholar
Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L. & Gao, G. Viral vector platforms within the gene therapy landscape. Signal Transduct. Target. Ther. 6, 53 (2021).
Google Scholar
Zhu, Y. et al. Multi-step screening of DNA/lipid nanoparticles and co-delivery with siRNA to enhance and prolong gene expression. Nat. Commun. 13, 4282 (2022).
Google Scholar
Guimaraes, L. C. et al. Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models. Nat. Commun. 15, 590 (2024).
Google Scholar
Liao, H.-C. et al. Lipid nanoparticle-encapsulated DNA vaccine robustly induce superior immune responses to the mRNA vaccine in Syrian hamsters. Mol. Ther. Methods Clin. Dev. 32, 101169 (2024).
Google Scholar
Nguyen, T. N. et al. Lipid nanoparticle-encapsulated DNA vaccine confers protection against swine and human-origin H1N1 influenza viruses. mSphere 9, e0028324 (2024).
Google Scholar
Yu, L. & Liu, P. Cytosolic DNA sensing by cGAS: regulation, function, and human diseases. Signal Transduct. Target. Ther. 6, 170 (2021).
Google Scholar
Cheng, Z. et al. The interactions between cGAS-STING pathway and pathogens. Signal Transduct. Target. Ther. 5, 91 (2020).
Google Scholar
Hansen, A. L. et al. Nitro-fatty acids are formed in response to virus infection and are potent inhibitors of STING palmitoylation and signaling. Proc. Natl Acad. Sci. USA 115, E7768–E7775 (2018).
Google Scholar
Pardi, N. et al. Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. Nat. Commun. 8, 14630 (2017).
Google Scholar
Chase, L. S., Zaleski, M. H., Morrell, L. J. & Brenner, J. S. Automated measurement of distance-walked as a ‘sixth vital sign’ for detecting infusion reactions during preclinical testing. Int. J. Pharm. 645, 123369 (2023).
Google Scholar
Domizio, J. D. et al. The cGAS–STING pathway drives type I IFN immunopathology in COVID-19. Nature 603, 145–151 (2022).
Google Scholar
Zhang, X., Goel, V. & Robbie, G. J. Pharmacokinetics of patisiran, the first approved RNA interference therapy in patients with hereditary transthyretin-mediated amyloidosis. J. Clin. Pharmacol. 60, 573–585 (2020).
Google Scholar
Schoenmaker, L. et al. mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability. Int. J. Pharm. 601, 120586 (2021).
Google Scholar
Parhiz, H. et al. Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE). J. Control. Release 344, 50–61 (2022).
Google Scholar
Banete, A., Barilo, J., Whittaker, R. & Basta, S. The activated macrophage—a tough fortress for virus invasion: how viruses strike back. Front. Microbiol. 12, 803427 (2022).
Sasaki, A. & Kinjo, M. Monitoring intracellular degradation of exogenous DNA using diffusion properties. J. Control. Release 143, 104–111 (2010).
Google Scholar
Wang, D., Zhao, H., Shen, Y. & Chen, Q. A variety of nucleic acid species are sensed by cGAS, implications for its diverse functions. Front. Immunol. 13, 826880 (2022).
Google Scholar
Melo, T., Montero-Bullón, J.-F., Domingues, P. & Domingues, M. R. Discovery of bioactive nitrated lipids and nitro-lipid-protein adducts using mass spectrometry-based approaches. Redox Biol. 23, 101106 (2019).
Google Scholar
Khoo, N. K. H., Li, L., Salvatore, S. R., Schopfer, F. J. & Freeman, B. A. Electrophilic fatty acid nitroalkenes regulate Nrf2 and NF-κB signaling: a medicinal chemistry investigation of structure-function relationships. Sci. Rep. 8, 2295 (2018).
Google Scholar
Kaminski, J. J. et al. Synthetic oligodeoxynucleotides (ODN) containing suppressive TTAGGG motifs inhibit AIM2 inflammasome activation. J. Immunol. 191, 3876–3883 (2013).
Google Scholar
Tao, R. et al. Long-term metabolic correction of phenylketonuria by AAV-delivered phenylalanine amino lyase. Mol. Ther. Methods Clin. Dev. 19, 507–517 (2020).
Google Scholar
Sperinde, J. J., Choi, S. J. & Szoka, F. C. Phage display selection of a peptide DNase II inhibitor that enhances gene delivery. J. Gene Med. 3, 101–108 (2001).
Google Scholar
Bai, H., Lester, G. M. S., Petishnok, L. C. & Dean, D. A. Cytoplasmic transport and nuclear import of plasmid DNA. Biosci. Rep. 37, BSR20160616 (2017).
Google Scholar
Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing. Nat. Nanotechnol. 15, 313–320 (2020).
Google Scholar
Wei, T. et al. Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models. Nat. Commun. 14, 7322 (2023).
Google Scholar
Omo-Lamai, S. et al. Physicochemical targeting of lipid nanoparticles to the lungs induces clotting: mechanisms and solutions. Adv. Mater. 36, e2312026 (2024).
Google Scholar
Zaleski, M. H. et al. Nanocarriers’ repartitioning of drugs between blood subcompartments as a mechanism of improving pharmacokinetics, safety, and efficacy. J. Control. Release 374, 425–440 (2024).
Google Scholar
Jacob, A. et al. Differentiation of human pluripotent stem cells into functional lung alveolar epithelial cells. Cell Stem Cell 21, 472–488 (2017).
Google Scholar
Jacob, A. et al. Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells. Nat. Protoc. 14, 3303–3332 (2019).
Google Scholar
Abo, K. M. et al. Air–liquid interface culture promotes maturation and allows environmental exposure of pluripotent stem cell–derived alveolar epithelium. JCI Insight 7, e155589 (2022).
